1. Foundation of Innovative New Diagnostics (FIND) . SARS-COV-2 Diagnostics Pipeline , 2020. www.finddx.org/covid-19/pipeline/ Date last accessed: 15 Oct 2020.
2. World Health Organization . WHO Interim Guidance 11 September 2020. Antigen-detection in the Diagnosis of SARS-CoV-2 Infection using Rapid Immunoassays. https://apps.who.int/iris/bitstream/handle/10665/334253/WHO-2019-nCoV-Antigen_Detection-2020.1-eng.pdf?sequence=1&isAllowed=y Date last accessed: 15 Oct 2020.
3. World Health Organization . WHO News Release 28 September 2020. Global Partnership to Make Available 120 Million Affordable, Quality COVID-19 Rapid Tests for Low- and Middle-income Countries. www.who.int/news-room/detail/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries. Date last accessed: 15 Oct 2020.
4. Krueger LJ , Gaeddert M , Koeppel L , et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv 2020; preprint [https://doi.org/10.1101/2020.10.01.20203836].
5. Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing